NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer Chairman & CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value.
CONTACT: Steven Lee Steven.Lee@guggenheimpartners.com
NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…
Global Times: Feng Jicai leads efforts to preserve China's cultural heritage through art, literature, and…
Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) -- Boston Hemp Inc., a leader in…
NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights…
NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor…
The latest data release from the Commodity Futures Trading Commission (CFTC) reveals a marginal improvement…
This website uses cookies.